A UK policy on 'take home naloxone' for opiate users - Strategy or stalemate?

Drugs: Education, Prevention and Policy

Volumn 10, Issue 2, 2003, Pages 105-119

  Oldham, Nicola S ^a   Wright, Nat M J ^a  

^a NFA Health Centre for Homeless People   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038052990     PISSN: 09687637     EISSN: None     Source Type: Journal    
DOI: 10.1080/0968763031000072251     Document Type: Review

References (59)

1. ACMD (1998). Drug misuse and the environment: a report by the Advisory Council on the Misuse of Drugs. London: Her Majesty's Stationery Office.
2. ACMD (2000). Reducing drug related deaths: a report by the Advisory Council on the Misuse of Drugs. London: Her Majesty's Stationery Office.
3. BARTON, E.D., RAMOS, J., COLWELL, C., BENSON, J., BAILY, J. & DUNN, W. (2001). Intranasal administration of naloxone by paramedics. Could this be a better practice? Presented at ACEP Research Forum, Chicago, October 2001.
4. BARTON, E.D., RAMOS, J., COLWELL, C., BENSON, J., BAILY, J. & DUNN, W. (2002). A preliminary report on intranasal administration of naloxone by paramedics: could this be a better practice? Prehospital Emergency Care, 5(1).
5. BENNETT, G.A. & HIGGINS, D.S. (1999). Accidental overdose among injecting drug users in Dorset, UK. Addiction, 94(8), 1179-1190.
6. BEST, D., MAN, L., ZADOR, D., DARKE, S., BIRD, S., STRANG, J. & ASHTON, M. (2000a). Overdosing on Opiates. Part 1: Causes. Drug and Alcohol Findings, 4, 4-20.
7. BEST, D., MAN, L., GOSSOP, M., NOBLE, A. & STRANG, J. (2000b). Drug user's experiences of witnessing overdose: What do they know and what do they need to know? Drug and Alcohol Review, 19, 407- 412.
8. BIGG, D. (2002). Data on take home naloxone are unclear but not condemnatory. British Medical Journal, 324, 678.
9. BLUTHENTHAL, R., KRAL, A.H., LAUREN, G.R., ERRINGER, E.A. & EDLIN, B.R. (2000). The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS, 14(5), 605-611.
10. BRUGAL, M.T., BARRIO, G., FUENTE, L., REGIDOR, E., ROYUELA, L. & SUELVES, J.M. (2002). Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction, 97, 319-327.
11. CAMBRIDGE INTERNATIONAL DICTIONARY OF ENGLISH (2002). http://www.dictionary.cambridge.org/define.
12. CLARKE, H.W. & CORBETT, J.M. (1993). Needle-exchange programs and social policy. Journal of Mental Health Administration, 20(1), 66-71.
13. CULLEN, W., BURY, G. & LANGTON, D. (2000). Experience of heroin overdose among drug users attending general practice. British Journal of General Practice, 50, 546-549.
14. DARKE, S. & HALL, W. (1997). The distribution of naloxone to heroin users. Addiction, 92(9), 1195-1199.
15. DARKE, S. & ROSS, J. (1999). Heroin-related deaths in Southern Western Sydney, Australia 1992-1996. Drug and Alcohol Review, 18, 39-45.
16. DARKE, S. & ZADOR, D. (1996). Fatal heroin 'overdose': a review. Addiction, 91(12), 1765-1772.
17. DARKE, S., ROSS, J. & HALL, W. (1996a). Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction, 91(3), 405-411.
18. DARKE, S., ROSS, J. & HALL, W. (1996b). Overdose among heroin users in Sydney, Australia: II. Responses to overdose. Addiction, 91(3), 413-417.
19. DARKE, S., ROSS, J., ZADOR, D. & SUNJIC, S. (2000). Heroin-related deaths in New South Wales, Australia 1992-1996. Drug and Alcohol Dependence, 60(2), 141-150.
20. DAVOLI, M., PERUCCI, C.A., RAPITI, E., BARGAGLI, A.M., D'IPPOLITI, D., FORASTIERE, F. & ABENI, D. (1997). A persistent rise in mortality among injection drug users in Rome, 1980 through 1992. American Journal of Public Health, 87(5), 851-853.
21. DEPARTMENT OF HEALTH (1999). The Scottish Office, Welsh Office, and Department of Health and Social Services. Drug Misuse and Dependence Guidelines on Clinical Management.
22. DESJARLAIS, D.C., MARMOR, M., PAONE, D., TITUS, S., SHI, Q., PERLIS, T., JOSE, B. & FRIEDMAN, S.R. (1996). HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet, 348, 987-991.
23. DETTMER, K., SAUNDERS, B. & STRANG, J. (2001). Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. British Medical Journal, 322, 895-896.
24. DRUGSCOPE (2002). OD: going over. London: Department of Health and Exchange Campaigns.
25. FITZPATRICK, S., KEMP, P. & KLINKER, S. (2000). Single homelessness: an overview of research in Britain. London: The Policy Press.
26. FRISHER, M., HICKMAN, M., KRAYS, L., MARIANI, F. & WIESSING, L. (2001). A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain. Addiction, 96, 1465-1476.
27. FRY, C., DIETZE, P. & CROFTS, N. (2000). Naloxone distribution: remembering hepatitis C transmission as an issue. Addiction, 95(12), 1865-1866.
28. FUENTE, L., BARRIO, G., VICENTE, J., BRAVO, M. & SANTACREU, J. (1995). The impact of drug-related deaths on mortality among young adults in Madrid. American Journal of Public Health, 85, 102-105.
29. GLANTZ, L. (1996). Annotation: needle exchange programs and the law - time for a change. American Journal of Public Health, 86(8), 1077-1078.
30. GOSSOP, M., GRIFFITHS, P., POWIS, B., WILLIAMSON, S. & STRANG, J. (1996). Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. British Medical Journal, 313, 402.
31. GOSSOP, M., STEWART, D., TRECY, S. & MARSDEN, J. (2002). A prospective study of mortality among drug misusers during a four-year period after seeking treatment. Addiction, 97, 39-47.
32. GRAHAM, C.A., McNAUGHTON, G.W., IRELAND, A. & CASSELLS, K. (2001). Take home naloxone for opiate addicts. British Medical Journal, 323, 934.
33. HAGAN, H., DES JARLAIS, D.C., FRIEDMAN, S.R., PURCHASE, D. & ALTER, M.J. (1995). Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe-exchange program. American Journal of Public Health, 85, 1531-1537.
34. HALL, W. & DARKE, S. (1998). Trends in opiate overdose in Australia 1979-1995. Drug and Alcohol Dependence, 52(1), 71-77.
35. HALL, W. (1999). Reducing the toll of opioid overdose deaths in Australia 1979-1995. Drug and Alcohol Review, 18, 213-220.
36. HUANG, J. (2002). Anti-overdose drug praised in New Mexico. Portland Press Herald, Blethen Maine Newspapers, Inc.
37. JUNGE, B.V., LATKIN, C., RILEY, E. & VLAHOV, D. (2000). Syringe exchange not associated with social network formation: results from Baltimore. AIDS, 14(4), 423-426.
38. KLEE, H. & REID, P. (1998). Drug use among the young homeless: coping through self-medication. Health, 2(2), 115-134.
39. LENTON, S.R. & HARGREAVES, K.M. (2000a). Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? Medical Journal of Australia, 173, 260-263.
40. LENTON, S.R. & HARGREAVES, K.M. (2000b). A trial of naloxone for peer administration has merit but will the lawyers let it happen? Drug and Alcohol Review, 19, 365-369.
41. LORIMER, N., HOFMAN, P. & CHAUDRY, H. R. (1994). Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. The International Journal of the Addictions, 29(6), 819-827.
42. MANNING, F.J., INGRAHAM, L.H., DEROUIN, E.M., VAUGHN, M.S., KUKURA, F.C. & ST. MICHEL, G.R. (1983). Drug 'overdose' among US soldiers in Europe, 1978-1979. II. Psychological autopsies following deaths and near-deaths, International Journal of the Addictions, 18, 153-156.
43. NEALE, J. (2001). Don't overdo it: overdose prevention and extent. Drug Link, July/August, 18-22.
44. NMAC (2001). Department of Health, New Mexico; Public Health Division; Infectious Disease Prevention and Control Bureau. Title 7: Health, Chapter 32: Alcohol and Drug Abuse, Part 7: Authorization to Administer Opioid Antagonists.
45. NMSA (2001). Administration of Opioid Antagonists: 24-23-1. Authority to administer opioid antagonists; release from liability. 24-23-2. Health care professionals; release from liability. Emergency clauses - Laws 2001, Ch. 228, section 3 makes the act effective immediately. Approved April 3, 2001.
46. NP-SAD SURVEILLANCE REPORT (2002). Drug-related deaths as reported by coroners in England and Wales. No.8. European Centre for Addiction Studies.
47. O'DRISCOLL, P.T., McGOUGH, J., HOGAN, H., THIEDE, H., CRITCHLOW, C. & ALEXANDER, R. (2001). Predictors of accidental fatal drug overdose among a cohort of injection drug users. American Journal of Public Health, 91(6), 984-987.
48. OLIVER, P., KEEN, J., ROWSE, G. & MATHERS, N. (2001). Deaths from drugs of abuse in Sheffield, 1988: the role of prescribed medication. British Journal of General Practice, 51, 394-396.
49. POWIS, B., STRANG, J., GRIFFITHS, P., TAYLOR, C., WILLIAMSON, S., FOUNTAIN, J. & GOSSOP, M. (1999). Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction, 94(4), 471-478.
50. QUAGLIO, G., TALAMINI, G., LECHI, A., VENTURINI, L., LUGOBONI, F., ST GEORGES HOSPITAL MEDICAL SCHOOL & MEZZELANI, P. (2001). Study of 2708 heroin-related deaths in northern-eastern Italy 1985-98 to establish the main cause of death. Addiction, 96, 1127-1137.
51. ROUGH SLEEPERS UNIT (2001). Looking for change: the role and impact of begging on the lives of people who beg. http://www.dtlr.gov.uk/housing.
52. ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN (2002). British National Formulary, 43(March). London: British Medical Association & Royal Pharmaceutical Society.
53. SCHECHTER, M.T., STRATHDEE, S.A., CORNELISSE, P.G.A., CURRIE, S.P., REKART, M.L. & O'SHAUGHNESSY, M.V. (1999). Do needle-exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS, 13, F45-F51.
54. SEAL, K.H., KRAL, A.H., GEE, L., MOORE, L.D., BLUTHENTHAL, R.N., LORVICK, J. & EDIN, B.R. (2001). Predictors and prevention of non-fatal overdose among street-recruited injection heroin users in San Francisco Bay area, 1998-1999. American Journal of Public Health, 91(11), 1842-1847.
55. SEAMAN, S.R., BRETTLE, R.P. & GORE, M. (1998). Mortality from overdose among injecting drug users recently released from prison: database linkage study. British Medical Journal, 16, 426-428.
56. STRANG, J., BEVERLY, P., BEST, D., VINGOE, L., GRIFFITHS, P., TAYLOR, C., WELCH, S. & GOSSOP, M. (1999). Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction, 94(2), 199-204.
57. STRANG, J., DARKE, S., HALL, W., FARRELL, M. & ALI, R. (1996). Heroin overdose: the case for take-home naloxone. British Medical Journal, 312, 1435-1436.
58. WRIGHT, M.N.J. (2002). Homelessness: a primary care response. London: Royal College of General Practitioners.
59. ZADOR, D., SUNJIC, S. & DARKE, S. (1995). Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Medical Journal of Australia, 164, 204-207.